Arcutis Biotherapeutics, Inc. ARQT Business Segments
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Product revenue, net by Product | ||||
| ZORYVE Cream0.15 | $68.27M+588% | $9.92M— | —— | |
| ZORYVE Cream0.3 | $121M+42.2% | $85.08M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Arcutis Biotherapeutics, Inc. break its business down?
- Arcutis Biotherapeutics, Inc. (ARQT) reports product revenue, net by product across 3 parts — ZORYVE Cream0.05, ZORYVE Cream0.15 and ZORYVE Cream0.3. Each is extracted from the segment footnotes and tracked over time.
- Where does Arcutis Biotherapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Arcutis Biotherapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.